Skip to main content
Premium Trial:

Request an Annual Quote

Downloads and Upgrades: Archer Analysis Pipeline, POSIT 3.1, and Lasergene 12.1


Enzymatics has launched version 3.0 of its Archer Analysis Pipeline. It's the latest incarnation of the company's next-generation sequence analysis platform for detecting and characterizing cancer-causing gene fusions and mutations from clinical samples. The solution lets users call known or novel genomic alterations. It includes robust quality control systems, clear, detailed analytics, and interactive visualizations using JBrowse, among other features.

OpenEye has released POSIT 3.1, a new version of a component in its OEDocking suite that's used for pose prediction in lead optimization experiments. Enhancements to POSIT include the addition of HybridFit and SiteFit search technology as well as support for an unlimited number of receptors, and MPI-enabled parallel processing.

DNAStar has released Lasergene 12.1. This version of the solution integrates the company's traditional desktop software with cloud capabilities providing users with tools to run multiple sequence assemblies on remote infrastructure. The solution also includes DNAStar data drive, which enables fast, secure data transfer between desktop computers and the cloud. It also includes protein function and binding site prediction tools and more.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more